Drug Delivery and Emerging Therapies (S)

View entire schedule Show Abstracts for this session

Industry Sponsored Symposium

Thursday 26 June 2025, 14:15 - 15:15, Copacabana (200)

Moderators

Khayyam DURRANI, Victor LLORENS BELLES, Quan Dong NGUYEN

	14:15	Potential Role of Tissue Plasminogen Activator (TPA) in the Management of Uveitis		SPENCER D
	14:22	Potential Role of Regenerative Medicine in Treating the Complications of Ocular Inflammatory Diseases		DURRANI K
	14:29	Potential Role of Vamikivart in UME: Insights from the SANDCAT/MEERCAT Studies		LLORENS BELLES V
	14:36	Potential Role of OCS-01 in UME: What May We Learn from the LEOPARD Study		OR C
	14:43	Cell Therapy for Non-Infectious Uveitis: Insights into the PEACOCX Study		HUNG JH
	14:50	Laquinimod as Potential Therapeutic Approach for Non-Infectious Uveitis: What Have We Learned from the LION Study		EL FEQI D
	14:57	Can JAK-Inhibitor Be First-Line Non-Steroidal Therapy for Non-infectious Uveitis?		DACEY M
	15:04	Discussion
	15:15	End of Session